Suntec Medical, USA was established in 2005. It is located in Southern California, USA. After an aggressive business development, Suntec has established a strong International trading business of active pharmaceutical ingredients (API) and of key pharmaceutical products in US/EU and special targeted markets such as Latin America, and China.
Suntec currently has over 1000 formulated products with emphasis on biosimilars and advanced formulation such as PEGylated and extended release products. Many of them are either EU registered or manufactured under EMEA or PIC/s GMP quality system. Suntec also has over 700 APIs with many of them US/EU DMF ready.